Search - tctmd.com

Displaying 861 - 880 of 1025

Sort: Relevancy | Date

News Industry News

US FDA approves EPANOVA for the treatment of adults with severe hypertriglyceridaemia

May 06, 2014

News Daily News

No Endoleak at Initial Post-EVAR Imaging Predictive of Less Reintervention

April 28, 2014

News Daily News

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

L.A. McKeown

April 11, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

Presentation

Effect of Aleglitazar on Cardiovascular Outcomes after ACS in Patients with Type 2 Diabetes

Presenter: A. Michael Lincoff

April 04, 2014

News Daily News

FAST-MI Registry: Fibrinolysis, Primary PCI Yield Similar 5-Year Survival in STEMI Patients

L.A. McKeown

April 03, 2014

News Conference News ACC 2014

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Yael L. Maxwell

March 31, 2014

News Conference News ACC 2014

GIPS-III: Diabetes Drug Metformin Not Cardioprotective in Nondiabetic STEMI Patients After Primary PCI

Jason Kahn

March 31, 2014

News Industry News

Takeda Presents Additional Data from the EXAMINE Cardiovascular Safety Outcomes Trial at the American College of Cardiology's 63rd Annual Scientific Session

March 27, 2014

News Daily News

GENESIS-PRAXY: Young Women with ACS Experience Worse Access to Care than Men

March 27, 2014

News Daily News

HORIZONS-AMI: Kidney Damage During Primary PCI Closely Tied to Prognosis

March 20, 2014

News Daily News

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Caitlin E. Cox

March 13, 2014

News Daily News

ZES Continue to Match EES in All Comers at 4 Years

March 13, 2014

News Daily News

Registry Suggests Link Between PCI Access Route, Kidney Damage

Caitlin E. Cox

March 05, 2014

News Daily News

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

Yael L. Maxwell

February 17, 2014

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2013

Yael L. Maxwell

January 27, 2014

News Daily News

STROLL at 3 Years: Nitinol Stent Demonstrates Sustained Patency, QoL in SFA Patients

L.A. McKeown

January 20, 2014

News Daily News

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

January 09, 2014

News Daily News

Comparados con los SMD, los SLE Reducen la Revascularización con Independencia de la Severidad de la Enfermedad Renal

January 09, 2014

News Daily News

Meta-analysis: CABG Bests PCI for Long-term Morbidity, Mortality in Multivessel CAD

Yael L. Maxwell

December 30, 2013

Advertisement

US FDA approves EPANOVA for the treatment of adults with severe hypertriglyceridaemia

No Endoleak at Initial Post-EVAR Imaging Predictive of Less Reintervention

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

Effect of Aleglitazar on Cardiovascular Outcomes after ACS in Patients with Type 2 Diabetes

FAST-MI Registry: Fibrinolysis, Primary PCI Yield Similar 5-Year Survival in STEMI Patients

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

GIPS-III: Diabetes Drug Metformin Not Cardioprotective in Nondiabetic STEMI Patients After Primary PCI

Takeda Presents Additional Data from the EXAMINE Cardiovascular Safety Outcomes Trial at the American College of Cardiology's 63rd Annual Scientific Session

GENESIS-PRAXY: Young Women with ACS Experience Worse Access to Care than Men

HORIZONS-AMI: Kidney Damage During Primary PCI Closely Tied to Prognosis

DES Outcomes Vary by Diabetes Status, Lesion Complexity

ZES Continue to Match EES in All Comers at 4 Years

Registry Suggests Link Between PCI Access Route, Kidney Damage

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

Year in Review: Physicians Highlight the Most Important Interventional News of 2013

STROLL at 3 Years: Nitinol Stent Demonstrates Sustained Patency, QoL in SFA Patients

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

Comparados con los SMD, los SLE Reducen la Revascularización con Independencia de la Severidad de la Enfermedad Renal

Meta-analysis: CABG Bests PCI for Long-term Morbidity, Mortality in Multivessel CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content